Lupin Pharmaceuticals Inc. Sertraline Hydrochloride Tablets USP, 100 mg recall: Defective container - seal not adhering to bottles
Defective container - seal not adhering to bottles
The hazard: Drug safety concern
This is an FDA enforcement action. The summary above is the agency’s own description of what went wrong.
What the notice says: Defective container - seal not adhering to bottles
Why it matters: The FDA recorded an enforcement action against this product. The classification and the summary above describe how serious the agency considers it.
Recall details
- Recall number
- D-0227-2026
- Published
- December 17, 2025
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Lupin Pharmaceuticals Inc.
- Product type
- Prescription & OTC drugs
- Units affected
- 52,128 bottles
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot # QB00865, exp. date Feb 2028
Products covered by this recall
Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.
Check your product
The notice names 6 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- QB00865
- 128 bottles
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- Feb 2028 — 52
- 128 bottles
NDC number
On the carton and again on the bottle or blister label.
- 68180-353-09
Package size
Match the net weight or the piece count on the front of the pack.
- 100 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Drug safety
Lupin Pharmaceuticals Inc. — This is an FDA enforcement action. The summary above is the agency’s own description of what went wrong.
- Check the lot number on your pack against the codes listed above.
- Report side effects you think the product caused to FDA MedWatch.
- Do not stop a prescribed medicine on your own — speak to your prescriber or pharmacist first.
- Ask the dispensing pharmacy for a replacement from an unaffected lot.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue.
- If the recall voided a fill you had already paid for, your insurer will normally authorise a replacement ahead of schedule. Quote the recall number.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price and keep the receipt the pharmacy issues.
Company contact: Lupin Pharmaceuticals Inc. — 5801 Pelican Bay Blvd, Naples, FL, 34108-2755
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Lupin Pharmaceuticals Inc. prescription & otc drugs recalled?
Defective container - seal not adhering to bottles Defective container - seal not adhering to bottles
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code QB00865, 128 bottles; best-by date Feb 2028 — 52 or 128 bottles. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above.
Can I get my money back?
Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · last month
Lupin Pharmaceuticals Inc. Clobetasol Propionate Cream USP, 0.05%, 60 g tube recall: Failed content uniformity specifications
Failed content uniformity specifications.
-
Class II · 4 months ago
Lupin Pharmaceuticals Inc. Glucagon Emergency Kit for Low Blood Sugar recall: CGMP deviation: OOS result observed for the Gliding Force functionality test
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
-
Class II · 4 months ago
Lupin Pharmaceuticals Inc. prednisoLONE Acetate Ophthalmic Suspension, USP, 1% recall: Presence of Foreign Substance
Presence of Foreign Substance
-
Class II · 5 months ago
Lupin Pharmaceuticals Inc. Liraglutide Injection, 18 mg/3 mL recall: Presence of particulate matter: a white thread-like structure in the cartridge
Presence of particulate matter: a white thread-like structure in the cartridge
-
Class II · 10 months ago
Lupin Pharmaceuticals Inc. Ganirelix Acetate Injection, 250 mcg/0.5mL recall: Failed impurities/degradation specifications: out of specification results
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility